Correction to "Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia". . Cancer 2026;132:e70347.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Correction to "Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia". Cancer 2026;132:e70347.
PMID: 41823509